A randomized, open-label, standard controlled, parallel group study of efficacy and safety of baclofen, and chlordiazepoxide in uncomplicated alcohol withdrawal syndrome

Biomedical Journal

Volumn 39, Issue 1, 2016, Pages 72-80

  Girish, K ^a   Vikram Reddy, K ^a   Pandit, Lakshmi V ^a   Pundarikaksha, H P ^a   Vijendra, R ^a   Vasundara, K ^a   Manjunatha, R ^a   Nagraj, Moulya ^a   Shruthi, R ^a  

^a KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alcohol withdrawal syndrome; Baclofen; Chlordiazepoxide; Clinical Global Impression scores; Clinical Institute Withdrawal Assessment for Alcohol Revised Scale

Indexed keywords

BACLOFEN; CHLORDIAZEPOXIDE; LORAZEPAM; DIAZEPAM;

ABNORMAL URINE COMPOSITION; ADULT; AGITATION; ALCOHOL WITHDRAWAL; ANXIETY; ARTICLE; BEHAVIOR DISORDER ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL REVISED SCALE; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEVER; HUMAN; LOOSE FECES; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PARALLEL DESIGN; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; URINE COMPOSITION DISORDER; URINE DISCOLORATION; VISUAL ANALOG SCALE; DRINKING BEHAVIOR; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

ADULT; ALCOHOL DRINKING; BACLOFEN; CHLORDIAZEPOXIDE; DIAZEPAM; HUMANS; LORAZEPAM; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 84978062906     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bj.2015.09.002     Document Type: Article

References (14)

1. [1] Room, R., Babor, T., Rehm, J., Alcohol and public health. Lancet 365 (2005), 519–530.
2. [2] Ranganathan TT. Alcohol related harm in India – a fact sheet. Available from: http://www.addictionindia.org/images-ttkh/alcohol-related-harm-in-india-a-fact-sheet.pdf [last accessed 09.06.13.].
3. [3] Hartsell, Z., Drost, J., Wilkens, J.A., Budavari, A.I., Managing alcohol withdrawal in hospitalized patients. JAAPA 20 (2007), 20–25.
4. [4] Amato, L., Minozzi, S., Davoli, M., Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database Syst Rev, 2011 Available from: http://www.onlinelibrary.wiley.com/doi/10.1002/14651858.CD008537.pub2/pdf [last accessed 09.06.13.].
5. [5] Addolorato, G., Leggio, L., Abenavoli, L., Agabio, R., Caputo, F., Capristo, E., et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs. diazepam. Am J Med 119 (2006), 276.e13–276.e18.
6. [6] Liu, J., Wang, L., Baclofen for alcohol withdrawal. Cochrane Database Syst Rev, 2011 Available from: http://www.onlinelibrary.wiley.com/doi/10.1002/14651858.CD008502/pdf [last accessed on 09.06.13.].
7. [7] Ashton, H., The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 18 (2005), 249–255.
8. [8] Kenny, P., Swan, A., Berends, L., Jenner, L., Hunter, B., Mugavin, J., Alcohol and other drug withdrawal: practice guidelines. 2009 Available from: http://www.dacas.org.au/Clinical_Resources/GetFile.axd?oid=34970bb7-3486-4295-af17-e82c3f683d02 [last accessed 09.06.13.].
9. [9] Shirley, K.W., Kothare, S., Piatt, J.H. Jr., Adirim, T.A., Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care 22 (2006), 258–261.
10. [10] Zuckerbraun, N.S., Ferson, S.S., Albright, A.L., Vogeley, E., Intrathecal baclofen withdrawal: emergent recognition and management. Pediatr Emerg Care 20 (2004), 759–764.
11. [11] Lamoure, J., Stovel, J., Abrupt stop: managing discontinuation syndrome associated with psychoactive medications. Pharm Pract 26 (2010), 40–53.
12. [12] Kumar, C.N., Andrade, C., Murthy, P., A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal. J Stud Alcohol Drugs 70 (2009), 467–474.
13. [13] Prasad, R., Alcohol use on the rise in India. Lancet 373 (2009), 17–18.
14. [14] Sweetman, S.C., (eds.) Muscle relaxants. Martindale: the complete drug reference, 36th ed., 2009, Pharmaceutical Press, London, 1888–1890.